177 related articles for article (PubMed ID: 34064451)
1. Botulinum Toxin Type-A (Botulax
Kim H; Jang B; Kim ST
Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34064451
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study.
Taylor M; Silva S; Cottrell C
Headache; 2008; 48(10):1476-81. PubMed ID: 19076646
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A for neuropathic pain in patients with spinal cord injury.
Han ZA; Song DH; Oh HM; Chung ME
Ann Neurol; 2016 Apr; 79(4):569-78. PubMed ID: 26814620
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute dysmenorrhoea and pelvic pain syndrome of uterine origin with myometrial botulinum toxin injections under hysteroscopy: A pilot study.
Bautrant E; Franké O; Amiel C; Bensousan T; Thiers-Bautrant D; Levêque C
J Gynecol Obstet Hum Reprod; 2021 Apr; 50(4):101972. PubMed ID: 33186771
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial.
Attal N; de Andrade DC; Adam F; Ranoux D; Teixeira MJ; Galhardoni R; Raicher I; Üçeyler N; Sommer C; Bouhassira D
Lancet Neurol; 2016 May; 15(6):555-65. PubMed ID: 26947719
[TBL] [Abstract][Full Text] [Related]
6. Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraine.
Bratbak DF; Nordgård S; Stovner LJ; Linde M; Dodick DW; Aschehoug I; Folvik M; Tronvik E
Cephalalgia; 2017 Apr; 37(4):356-364. PubMed ID: 27154997
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound-guided greater occipital nerve block with botulinum toxin for patients with chronic headache in the occipital area: a randomized controlled trial.
Ryu JH; Shim JH; Yeom JH; Shin WJ; Cho SY; Jeon WJ
Korean J Anesthesiol; 2019 Nov; 72(5):479-485. PubMed ID: 31159537
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin in the treatment of trigeminal neuralgia: 6-Month follow-up.
Türk Börü Ü; Duman A; Bölük C; Coşkun Duman S; Taşdemir M
Medicine (Baltimore); 2017 Sep; 96(39):e8133. PubMed ID: 28953646
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous botulinum toxin-A injection for treating postherpetic neuralgia.
Hu Y; Zou L; Qi X; Lu Y; Zhou X; Mao Z; Chen X; Liu K; Yang Y; Wu Z; Hu Y; Ma S
Dermatol Ther; 2020 Jan; 33(1):e13181. PubMed ID: 31769900
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type-A therapy in cluster headache: an open study.
Sostak P; Krause P; Förderreuther S; Reinisch V; Straube A
J Headache Pain; 2007 Sep; 8(4):236-41. PubMed ID: 17901920
[TBL] [Abstract][Full Text] [Related]
11. Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial.
Zhang H; Lian Y; Ma Y; Chen Y; He C; Xie N; Wu C
J Headache Pain; 2014 Sep; 15(1):65. PubMed ID: 25263254
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin and intractable trigeminal neuralgia.
Türk U; Ilhan S; Alp R; Sur H
Clin Neuropharmacol; 2005; 28(4):161-2. PubMed ID: 16062093
[TBL] [Abstract][Full Text] [Related]
13. Treatment of occipital neuralgia using onabotulinum toxin A.
Marcolla IMG; Camargo CHF; Coutinho L; Ferreira MG; Tiburtino Meira A; Piovesan EJ; Ghizoni Teive HA
Acta Neurol Scand; 2022 Feb; 145(2):193-199. PubMed ID: 34542909
[TBL] [Abstract][Full Text] [Related]
14. Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic cluster headache.
Bratbak DF; Nordgård S; Stovner LJ; Linde M; Folvik M; Bugten V; Tronvik E
Cephalalgia; 2016 May; 36(6):503-9. PubMed ID: 26232105
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin as a novel therapeutic approach for auriculotemporal neuralgia.
Pinto MJ; Guerrero AL; Costa A
Headache; 2021 Feb; 61(2):392-395. PubMed ID: 33433917
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of botulinum toxin for interstitial cystitis/painful bladder syndrome.
Gottsch HP; Miller JL; Yang CC; Berger RE
Neurourol Urodyn; 2011 Jan; 30(1):93-6. PubMed ID: 20589903
[TBL] [Abstract][Full Text] [Related]
17. [Subcutaneous botulinum toxin in the treatment of peripheral neuropathic pain].
Puentes Gutiérrez AB; García Bascones M; Puentes Gutiérrez R; Díaz Jiménez M
Rehabilitacion (Madr); 2019; 53(2):131-135. PubMed ID: 31186096
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin occipital nerve block for the treatment of severe occipital neuralgia: a case series.
Kapural L; Stillman M; Kapural M; McIntyre P; Guirgius M; Mekhail N
Pain Pract; 2007 Dec; 7(4):337-40. PubMed ID: 17986166
[TBL] [Abstract][Full Text] [Related]
19. Comparison Between Steroid and 2 Different Sites of Botulinum Toxin Injection in the Treatment of Lateral Epicondylalgia: A Randomized, Double-Blind, Active Drug-Controlled Pilot Study.
Guo YH; Kuan TS; Chen KL; Lien WC; Hsieh PC; Hsieh IC; Chiu SH; Lin YC
Arch Phys Med Rehabil; 2017 Jan; 98(1):36-42. PubMed ID: 27666156
[TBL] [Abstract][Full Text] [Related]
20. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
Lang AM
Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
